S. Adak

Phase II Trial of Docetaxel, Cisplatin, Fluorouracil, and Leucovorin as Induction for Squamous Cell Carcinoma of the Head and Neck

A. Dimitrios Colevas, Charles M. Norris, Roy B. Tishler et al. · Journal of Clinical Oncology · 1999 · 126 citations

Medicine, Oncology, Radiation Oncology +11

Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.

A. Dimitrios Colevas, Paul M. Busse, Charles M. Norris et al. · Journal of Clinical Oncology · 1998 · 113 citations

Medicine, Oncology, Radiation Oncology +14

Predicting the rate of cognitive decline in aging and early Alzheimer disease

S. Adak, K. Illouz, W. Gorman et al. · Neurology · 2004 · 93 citations

Medicine, Neurology, Neuroscience +17

Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593.

Minesh P. Mehta, Scott P. Tannehill, S. Adak et al. · Journal of Clinical Oncology · 1998 · 62 citations

Medicine, Oncology, Radiation Oncology +14

Phase I/II Trial of Outpatient Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (opTPFL) as Induction for Squamous Cell Carcinoma of the Head and Neck (SCCHN)

A. Dimitrios Colevas, Charles M. Norris, Roy B. Tishler et al. · American Journal of Clinical Oncology · 2002 · 55 citations

Medicine, Oncology, Radiation Oncology +16